12 Einträge gefunden

1. Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?

   1. Demiralay, Cüneyt
   2. Agorastos, Agorastos
   3. Yassouridis, Alexander
   4. Jahn, Holger
   5. Wiedemann, Klaus
   6. Kellner, Michael

   2017 - Forschungsinformationssystem des UKE
2. No effects of antidepressants on negative symptoms in schizophrenia

   1. Hinkelmann, Kim
   2. Yassouridis, Alexander
   3. Kellner, Michael
   4. Jahn, Holger
   5. Wiedemann, Klaus
   6. Raedler, Thomas J

   2013 - Forschungsinformationssystem des UKE
3. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.

   1. Demiralay, Cüneyt
   2. Jahn, Holger
   3. Kellner, Michael
   4. Yassouridis, Alexander
   5. Wiedemann, Klaus

   2012 - Forschungsinformationssystem des UKE
4. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.

   1. Hinkelmann, Kim
   2. Yassouridis, Alexander
   3. Mass, Reinhard
   4. Tenge, Henrike
   5. Kellner, Michael
   6. Jahn, Holger
   7. Wiedemann, Klaus

   2010 - Forschungsinformationssystem des UKE
5. Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.

   1. Demiralay, Cüneyt
   2. Jahn, Holger
   3. Kellner, Michael
   4. Yassouridis, Alexander
   5. Wiedemann, Klaus

   2010 - Forschungsinformationssystem des UKE
6. Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study.

   1. Otte, Christian
   2. Hinkelmann, Kim
   3. Moritz, Steffen
   4. Yassouridis, Alexander
   5. Jahn, Holger
   6. Wiedemann, Klaus
   7. Kellner, Michael

   2009 - Forschungsinformationssystem des UKE
7. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.

   1. Jahn, Holger
   2. Schick, Mildred
   3. Kiefer, Falk
   4. Kellner, Michael
   5. Yassouridis, Alexander
   6. Wiedemann, Klaus

   2004 - Forschungsinformationssystem des UKE
8. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.

   1. Kellner, Michael
   2. Otte, Christian
   3. Yassouridis, Alexander
   4. Schick, Mildred
   5. Jahn, Holger
   6. Wiedemann, Klaus

   2004 - Forschungsinformationssystem des UKE
9. Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide.

   1. Arlt, Josef
   2. Jahn, Holger
   3. Kellner, Michael
   4. Ströhle, Andreas
   5. Yassouridis, Alexander
   6. Wiedemann, Klaus

   2003 - Forschungsinformationssystem des UKE
10. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.

    1. Otte, Christian
    2. Jahn, Holger
    3. Yassouridis, Alexander
    4. Arlt, Josef
    5. Stober, Nina
    6. Maass, Philip
    7. Wiedemann, Klaus

    2003 - Forschungsinformationssystem des UKE
11. Sleep endocrine effects of the 11-beta-hydroxysteroiddehydrogenase inhibitor metyrapone.

    1. Jahn, Holger
    2. Kiefer, Falk
    3. Schick, Mildred
    4. Yassouridis, Alexander
    5. Steiger, Axel
    6. Kellner, Michael
    7. Wiedemann, Klaus

    2003 - Forschungsinformationssystem des UKE
12. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans.

    1. Otte, Christian
    2. Yassouridis, Alexander
    3. Jahn, Holger
    4. Maass, Philipp
    5. Stober, Nina
    6. Wiedemann, Klaus
    7. Kellner, Michael

    2003 - Forschungsinformationssystem des UKE